{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T09:46:13Z","timestamp":1742636773709},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T00:00:00Z","timestamp":1374192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["currenttherapeuticres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.curtheres.2013.06.002","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T22:46:35Z","timestamp":1376606795000},"page":"33-38","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The Effect of Iloprost on Renal Function in Patients with Critical Limb Ischemia"],"prefix":"10.1016","volume":"75","author":[{"given":"Yasin","family":"Ay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Kara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuray Kahraman","family":"Ay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cemalettin","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cengiz","family":"Koksal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Durmus Alper","family":"Gorur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orhan","family":"Findik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.curtheres.2013.06.002_bib1","first-page":"1","article-title":"Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC)","volume":"31","author":"Dormandy","year":"2000","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.curtheres.2013.06.002_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/1358863X9600100212","article-title":"Prostanoid drug therapy for peripheral arterial occlusive disease: the European experience","volume":"1","author":"Dormandy","year":"1996","journal-title":"Vasc Med"},{"key":"10.1016\/j.curtheres.2013.06.002_bib3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2215\/CJN.01070905","article-title":"Renal insufficiency and use of revascularization among a national cohort of men with advanced lower extremity peripheral arterial disease","volume":"1","author":"O'Hare","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.curtheres.2013.06.002_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1160\/TH10-07-0499","article-title":"Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost","volume":"105","author":"Lessiani","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.curtheres.2013.06.002_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jss.2008.07.017","article-title":"Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization","volume":"157","author":"Coppolino","year":"2009","journal-title":"J Surg Res"},{"key":"10.1016\/j.curtheres.2013.06.002_bib6","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1160\/TH07-08-0509","article-title":"The prostacyclin analogue iloprost increases circulating endothelial progenitor cells in patients with critical limb ischemia","volume":"100","author":"Di Stefano","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.curtheres.2013.06.002_bib7","first-page":"7","article-title":"Effects of iloprost (a prostacyclin analogue) on the endothelial dysfunction and foot ulcers in diabetic patients with peripheral arterial disease","volume":"16","author":"Sert","year":"2008","journal-title":"Int J Diabetes Metab"},{"key":"10.1016\/j.curtheres.2013.06.002_bib8","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1161\/CIRCULATIONAHA.109.863159","article-title":"Iloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention","volume":"120","author":"Spargias","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.curtheres.2013.06.002_bib9","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/SHK.0b013e3181a1ba54","article-title":"The effect of iloprost on renal dysfunction after renal I\/R using cystatin C and beta2-microglobulin monitoring","volume":"32","author":"Sahsivar","year":"2009","journal-title":"Shock"},{"key":"10.1016\/j.curtheres.2013.06.002_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3810\/pgm.2001.12.1065","article-title":"Estimating the glomerular filtration rate","volume":"110","author":"Manjunath","year":"2001","journal-title":"Postgrad Med"},{"key":"10.1016\/j.curtheres.2013.06.002_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejvs.2006.09.024","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"33","author":"Norgren","year":"2007","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.curtheres.2013.06.002_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.curtheres.2013.06.002_bib13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.curtheres.2013.06.002_bib14","first-page":"53","article-title":"Cystatin C for GFR","volume":"35","author":"Grubb","year":"2001","journal-title":"Adr Clin Chem"},{"key":"10.1016\/j.curtheres.2013.06.002_bib15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","article-title":"Recommended standards for reports dealing with lower ex tremity ischemia: revised version","volume":"26","author":"Rutherford","year":"1997","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.curtheres.2013.06.002_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1053\/ajkd.2000.8237","article-title":"Serum sistatin C as a new marker for non-invasive estimation of glomerular filtration rate and as a marker for early renal impairment","volume":"36","author":"Coll","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.curtheres.2013.06.002_bib17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/clinchem\/48.5.699","article-title":"Sistatin C: an improved estimator of glomerular filtration rate?","volume":"48","author":"Laterza","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.curtheres.2013.06.002_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2004.09.025","article-title":"Sistatin C as a marker of GFR- history, indications, and future research","volume":"38a","author":"Filler","year":"2005","journal-title":"Clin Biochem"},{"key":"10.1016\/j.curtheres.2013.06.002_bib19","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1046\/j.1523-1755.2003.00925.x","article-title":"\u0130mpact of tyroid dysfunction on serum cystatin C","volume":"63","author":"Fricker","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.curtheres.2013.06.002_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/0886022X.2011.633446","article-title":"Affirmative effects of \u0131loprost on apoptosis during \u0131schemia-reperfusion \u0131njury in kidney as a distant organ","volume":"34","author":"Canacankatan","year":"2012","journal-title":"Renal Fail"},{"key":"10.1016\/j.curtheres.2013.06.002_bib21","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/CCM.0b013e31819b5f4e","article-title":"Iloprost preserves renal oxygenation and restores kidney function in endotoxemia-related acute renal failure in the rat","volume":"37","author":"Johannes","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.curtheres.2013.06.002_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1054\/plef.2001.0315","article-title":"PGl2 analogue mitigates the progression rate of renal dysfunction improving renal blood flow without glomerular hyperfiltration in patients with chronic renal insufficiency","volume":"65","author":"Fujita","year":"2001","journal-title":"Prostaglandins Leukot Essent Fatty Acids"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X13000209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X13000209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T21:13:36Z","timestamp":1596316416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X13000209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":22,"alternative-id":["S0011393X13000209"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2013.06.002","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effect of Iloprost on Renal Function in Patients with Critical Limb Ischemia","name":"articletitle","label":"Article Title"},{"value":"Current Therapeutic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.curtheres.2013.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}